A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.
Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.
Stanford Medicine researchers and others discovered 13 genetic signatures that are closely linked to an increased risk for severe COVID-19.
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.
Stanford Medicine’s early development of testing for COVID-19 infection and antibodies helped guide government responses and stem local spread of the virus.
There's a voracious appetite for information on how SARS-CoV-2, the virus responsible for the COVID-19 pandemic, works. Here it is, in a single package.
From how to quarantine to how to monitor your oxygen levels, a Stanford physician offers tips on what to do if you have COVID-19.
As the global health community celebrates the eradication of wild poliovirus in Africa, there are lessons that can apply to the COVID-19 pandemic.
A Stanford physician co-authored a list of likely biological factors underlying the reduced development of COVID-19 for children compared to adults.
The pandemic has been what one Stanford psychiatrist called “a mixed bag” for people with addiction issues; some find fewer triggers, others face more.
A Stanford researcher discusses how toxic pollutants can make people more susceptible to COVID-19 and why people of color are particularly vulnerable.
People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19.
Stanford experts provide tips for helping young children learn to wear a cloth mask to help prevent the spread of COVID-19.
How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?
Stanford Health Care chief of staff Megan Mahoney, MD, answers questions about how to avoid the spread of COVID-19 as restrictions are loosened.
